Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
Gleixner, K. V., Ferenc, V., Peter, B., Gruze, A., Meyer, R. A., Hadzijusufovic, E., Cerny-Reiterer, S., Mayerhofer, M., Pickl, W. F., Sillaber, C., Valent, P.Volume:
70
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-09-2181
Date:
February, 2010
File:
PDF, 588 KB
english, 2010